Related Experiment Video
Updated: Aug 11, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
How a single mutation alters the protein structure: a simulation investigation on protein tyrosine phosphatase SHP2
Yingnan Hou1,2, Xiaoli Lu1,2, Ziyao Xu3
1Westlake AI Therapeutics Lab, Westlake Laboratory of Life Sciences and Biomedicine 18 Shilongshan Road Hangzhou 310024 Zhejiang China huangjing@westlake.edu.cn.
Abstract:
Protein tyrosine phosphatase SHP2 is a key regulator modulating several signaling pathways. The oncogenic mutation E76K in SHP2 releases the enzyme from an autoinhibited, closed conformation into an active, open conformation. Here, we investigated the conformational dynamics of SHP2 and the effect of the E76K mutation on its conformational ensemble via extensive molecular dynamics (MD) and metadynamics (MetaD) simulations. Our simulations provide atomistic details on how the E76K mutated SHP2 prefers the open state and also reveal that the transition between the closed and the open states is highly collective. Several intermediate metastable states during the conformational transition between the closed and the open states were also investigated. Understanding how the single E76K mutation induces the conformational change in SHP2 could facilitate the further design of SHP2 inhibitors.
Insights
The E76K mutation in Protein tyrosine phosphatase SHP2 (SHP2) drives it to an active state. Molecular dynamics simulations reveal the mutation
Area of Science:
- Biochemistry and Molecular Biology
- Structural Biology
- Computational Biology
Background:
- Protein tyrosine phosphatase SHP2 (SHP2) is crucial for numerous signaling pathways.
- An oncogenic mutation, E76K, alters SHP2's conformation from closed to open, activating the enzyme.
Purpose of the Study:
- To investigate the conformational dynamics of SHP2.
- To understand the impact of the E76K mutation on SHP2's conformational ensemble.
Main Methods:
- Extensive molecular dynamics (MD) simulations.
- Metadynamics (MetaD) simulations were employed to explore conformational landscapes.
Main Results:
- The E76K mutation promotes a preference for the open, active conformation of SHP2.
- Conformational transitions between closed and open states are collective processes.
- Intermediate metastable states during these transitions were identified.
Conclusions:
- The E76K mutation stabilizes the active conformation of SHP2.
- Understanding these conformational dynamics aids in designing targeted SHP2 inhibitors.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Point and Frameshift Mutations
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Mutations
Amplifying Signals via Enzymatic Cascade

